Shame, Resilience and Well-being After Intimate Partner Violence: an Intervention Study With Replicated Single-Subject Design. (EMBER-4)
25 mai 2026 mis à jour par: Uppsala University
The EMBER protocol is a health care method that is designed to increase resilience, in order to improve well-being and overall health in women who have experienced violence by a partner.
This study explores whether the EMBER intervention works in this way.
Eight participants will take part in the EMBER program and complete questionnaires every week during the intervention.
The researchers will compare the timeline for the intervention to how resilience levels change.
They will also check whether changes in resilience are linked to changes in health and well-being.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Description détaillée
Intimate partner violence (IPV) is a global problem with complex consequences in society as well as for the victim/survivor.
The EMBER-protocol was developed at National Center for Knowledge on Men´s violence against Women, Uppsala University, Sweden.
The purpose of the protocol is to provide women who have been subjected to IPV with support and tools for empowerment and improving resilience, thereby improving health and well-being.
In this study with replicated single-case design, 8 patients will complete questionnaires bi-weekly while taking part of the intervention, starting from their very first contact with the clinic.
The questionnaires are completed using a mobile application.
Data will be processed using a combination of visual and statistical analysis, in order to examine how interventions intended to improve resilience, changes in resilience measures and changes in well-being and health relate to each other temporally.
Type d'étude
Interventionnel
Inscription (Estimé)
8
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Tove Filén, PhD-student
- Numéro de téléphone: +46186170785
- E-mail: tove.filen@nck.uu.se
Lieux d'étude
-
-
Uppsala County
-
Uppsala, Uppsala County, Suède, 75185
- Uppsala University Hospital
-
Contact:
- Tove Filén
- Numéro de téléphone: +46186170785
- E-mail: tove.filen@nck.uu.se
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- subjected to IPV within 2 years prior to enrollment
- capable of completing questionnaires using a mobile phone
- intention to complete intervention
- identifies as female
Exclusion Criteria:
- ongoing severe IPV
- ongoing severe substance use
- psychosis
- moderate to severe suicidality
- ongoing psychological intervention in other facility
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: EMBER intervention
|
A 4-step, Resilience-focused intervention based on the Resilience Portfolio Model, administered in individual format.
Autres noms:
A 4-step, Resilience-focused intervention based on the Resilience Portfolio Model, administered in group format.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Resilience - Psychological Endurance
Délai: Bi-weekly from enrollment 2-6 weeks prior to start of intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
The self assessment questionnaire Psychological Endurance Scale (range 6-24, higher value indicates higher endurance) is completed bi-weekly using a mobile application.
Data will be analyzed with a combination of visual and statistical analyses.
|
Bi-weekly from enrollment 2-6 weeks prior to start of intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
|
Resilience - Subjective Social Support
Délai: Bi-weekly from enrollment 2-6 weeks prior to start of intervention to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
The Oslo Subjective Social Support Scale - 3 items (range 3-14, higher value indicates higher level of social support) is completed bi-weekly using a mobile application.
Data will be processed using a combination of visual and statistical analyses.
|
Bi-weekly from enrollment 2-6 weeks prior to start of intervention to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
|
Resilience - Meaning Making
Délai: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
The MAPS - Meaningfulness subscale (range 5-25, higher value indicating higher meaningfulness) is completed by the subjects bi-weekly.
Data is processed using a combination of statistical and visual analyses.
|
Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Health
Délai: Bi-weekly from enrollment 2-6 weeks prior to the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
General, Somatic, Mental, Social and Sexual health is measured by 5 questions regarding subjective health the past week which are administered to the subject using a mobile application.
The subject grades ones health on a visuoanalogue scale ranging from -10 to +10.
The range on the total scale is thus -50 to +50, subscales -10 to +10.
Higher value indicates better health.
Data is processed using a combination in visual and statistical analyses.
|
Bi-weekly from enrollment 2-6 weeks prior to the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.
|
|
Shame
Délai: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 at weeks post-intervention.
|
Shame is measured using the External and Internal Shame Scale (EISS; range 0.00-4.00,
higher value indicating higher levels of shame), administered to patients using a mobile application.
Data is processed using a combination of statistical and visual analyses.
|
Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 at weeks post-intervention.
|
|
Well-Being
Délai: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up at 6 weeks post-intervention.
|
Well-being is measured bi-weekly using the Questionnaire on Well-Being (QWB, range 0-72, higher value indicating more wellbeing).
Data is processed using a combination of statistical and visual analyses.
|
Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up at 6 weeks post-intervention.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Carolina Överlien, Professor, The National Centre for Knowledge on Men's Violence Against Women, Uppsala university
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 juin 2026
Achèvement primaire (Estimé)
1 mai 2030
Achèvement de l'étude (Estimé)
1 juin 2030
Dates d'inscription aux études
Première soumission
25 mai 2026
Première soumission répondant aux critères de contrôle qualité
25 mai 2026
Première publication (Réel)
1 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
1 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
25 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- EMBER-4
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Resilience enhancing intervention, individual format
-
Faculty of Medicine, SousseInscription sur invitationAcquisition de connaissances | Engagements et motivationTunisie
-
Meryem OtuCumhuriyet UniversityComplété